跳到正文
原文
BMJ Open· Popa Ilie, I. R., Ghibu, S., Butuca, A., Dobrea, C. M., Frum, A., Stoicescu, L., Homorodean, C., Gligor, F. G., Morgovan, C.·· 2026-10-01AI 评分30

Tirzepatide在EudraVigilance中的安全性:优选术语描述性与不成比例性分析

Tirzepatide safety in EudraVigilance: descriptive and disproportionality analysis of preferred terms related to suboptimal treatment outcomes and drug-use-related issues

AI 导读

一项基于EudraVigilance数据库的回顾性药物警戒研究分析了Tirzepatide与药物使用问题相关的安全性报告。结果显示,Tirzepatide“药物无效”的报告比数(ROR)显著低于Liraglutide、Dulaglutide和Semaglutide(如vs Liraglutide ROR 0.61)。

来源:BMJ Open · bmjopen.bmj.com